Evopoint Biosciences
As of the edition of 20 October 2026, Evopoint Biosciences runs 6 drugs.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Active | 4 |
| Status not established | 2 |
| Total | 6 |
Where its trials are
- Cancer: 8 trials led
- Blood and lymph: 4 trials led
- Immune system: 4 trials led